| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 9e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |